| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Vaxcyte, Inc.'s insiders have reduced their positions by a net 45,442 shares worth roughly $3.7M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 429.9K | $26.14M | - | |
| COO | 145.4K | $8.84M | - | |
| CFO | 95.3K | $5.80M | - | |
| Other | 68.1K | $4.14M | - | |
| Other | 52.6K | $3.20M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 1, 2024 | Grant Pickering50 | Chief Executive Officer | Sell10b5-1 | 15,000 | $106.82 | $1,602,251.52 | -3.3% | -14.3% | -57.8% | |
| Nov 1, 2024 | Jim Wassil53 | Chief Operating Officer | Sale+OE10b5-1 | 8,000 | $106.80 | $854,422.60 | -3.7% | -14.3% | -57.8% | |
| Oct 18, 2024 | Andrew Guggenhime46 | President and CFO | Sale+OE10b5-1 | 42,000 | $115.39 | $4,846,508.21 | -31.7% | -24.0% | -63.3% | |
| Oct 7, 2024 | Mikhail Eydelman67 | SVP, Gen Counsel & Corp Sec | Sale+OE10b5-1 | 5,000 | $109.27 | $546,352.55 | -14.9% | -20.7% | -61.4% | |
| Oct 7, 2024 | Grant Pickering50 | Chief Executive Officer | Sell10b5-1 | 7,098 | $109.21 | $775,154.41 | -4.9% | -20.7% | -61.4% | |
| Oct 1, 2024 | Jim Wassil53 | Chief Operating Officer | Sale+OE10b5-1 | 8,000 | $114.24 | $913,917.45 | -3.8% | -29.0% | -67.1% | |
| Oct 1, 2024 | Grant Pickering50 | Chief Executive Officer | Sale+OE10b5-1 | 55,000 | $114.25 | $6,283,860.79 | -10.9% | -29.0% | -67.1% | |
| Oct 1, 2024 | Mikhail Eydelman67 | SVP, Gen Counsel & Corp Sec | Sale+OE10b5-1 | 5,500 | $114.24 | $628,294.76 | -16.1% | -29.0% | -67.1% | |
| Sep 18, 2024 | Andrew Guggenhime46 | President and CFO | Sale+OE10b5-1 | 8,000 | $115.94 | $927,550.51 | -8.1% | -22.9% | -72.0% | |
| Sep 17, 2024 | Teri Loxam | Director | Sale+OE10b5-1 | 6,250 | $116.28 | $726,730.95 | -46.6% | -23.3% | -73.5% |